A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
Katherine M. Bell-McGuinn, Carolyn M. Matthews, Steffan N. Ho, Minal Barve, Lucy Gilbert, Richard T. Penson, Ernst Lengyel, Rameshraja Palaparthy, Kye Gilder, Artemios Vassos, William McAuliffe, SaraVolume:
121
Année:
2011
Langue:
english
Pages:
7
DOI:
10.1016/j.ygyno.2010.12.362
Fichier:
PDF, 586 KB
english, 2011